Frontlight ResearchEarly access
Active, not recruitingNo phase
Cochlear Implantation in Children With Asymmetric Hearing Loss or Single-Sided Deafness Clinical Trial
Key facts
- Who runs it
- Washington University School of Medicine
- Where
- Los Angeles, Minneapolis, Oklahoma City, Philadelphia, and St Louis, United StatesSee the 5 sites
- Trial code
- Status
- Active, not recruiting
- People taking part
- 80 people, planned
- Started
- 20 Sept 2021
- Ended
- 30 Oct 2026
- Type of study
- Interventional
- Treatments tested
- Cochlear Implant
- Record updated
- 11 March 2026
Who can take part
- Age
- 4 years to 14 years
- Sex
- Women and men
- Healthy volunteers
- Can take part
The registry criteria, word for word
Show all 10 criteriaShow less
Who can take part
- At least 4 ys of age and up to 14 yrs, 11 mos of age and able to complete all investigational procedures
- Parents and child fluent in English. Parents desire bilateral hearing for their child, are willing to comply with study requirements, including the pre-implant HA phase, and are able to provide informed consent
- Poor ear (AHL/SSD): PTA at .5, 1, 2 kHz > 70 dB HL; Aided CNC word recognition score at 60 dB SPL < 40%; SPHL duration ≥ 6 mos and ≤ 10 yrs at time of CI surgery; If > 5 yrs of age, evidence of non-congenital SPHL onset (e.g., passed newborn hearing screening); If ≤ 5 yrs of age, no restrictions on SPHL onset
- Better ear
- AHL: PTA at .5, 1, 2, 4 kHz > 25 and ≤ 60 dB HL; Aided CNC word score at 60 dB SPL ≥ 55%; Currently using a HA; Stable hearing for the past 6-mo period. "Stable" is defined as thresholds that have not declined by more than 20 dB at three or more octave-interval audiometric frequencies
- SSD: PTA at .5, 1, 2, 4 kHz ≤ 25 dB HL; CNC word score at 60 dB SPL ≥ 70%; Stable hearing for the past 6-mo period
- Both ears of NH participants: PTA at .5, 1, 2, 4 kHz ≤ 25 dB HL
- To continue with cochlear implantation and into the CI phase of the study: Indication, via imaging, of a normal cochlear nerve and of cochlear anatomy in the ear to be implanted that allows full insertion of the electrode array. Imaging modality is at the discretion of the surgeon. In addition, better ear hearing must be stable throughout the HA phase
Who cannot take part
- Medical condition that contraindicates surgery; Actively using an implantable device in the ear to be implanted; Inability to complete study procedures; Unrealistic expectations related to the benefits and limitations of implantation; Unwillingness or inability to comply with all investigational requirements
- Exclusions for cochlear implantation and the CI phase of the study: Cochlear malformation or obstruction that would preclude full insertion of the electrode array in the ear to be implanted; Abnormal cochlear nerve in the ear to be implanted; Hearing loss of neural or central origin
Where in United States
- Keck School of Medicine of the University of Southern CaliforniaLos Angeles, United States
- Fairview Health ServicesMinneapolis, United States
- Hearts for HearingOklahoma City, United States
- Children's Hospital of Philadelphia - Buerger CenterPhiladelphia, United States
- Washington University School of Medicine/St. Louis Children's HospitalSt Louis, United States
About the trial
What the trial wants to find out
This is a two-phase study that compares performance growth pre-implant with current hearing aid (HA) technology versus post-implant with a cochlear implant (CI) in children with either asymmetric hearing loss (AHL) or single-sided deafness (SSD). Post-implant performance with a CI alone is expected to outperform pre-implant performance with a HA. The study also evaluates the effectiveness of bimodal hearing defined as a CI in the poor ear and a HA in the better ear for AHL or a CI in the poor ear and normal hearing in the better ear for SSD compared to pre-implant performance. The study examines factors contributing to CI outcomes.
The group in the trial
- AHL/SSDTreatment being tested
Children with asymmetric hearing loss or single-sided deafness
Treatment: Cochlear Implant
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Record updated
- 11 March 2026